Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adalimumab-associated optic neuritis.

Jacob H Chung1, Gregory P Van Stavern, Larry P Frohman

  • 1Institute of Ophthalmology and Visual Science, UMDNJ-New Jersey Medical School, P.O. Box 1709, Newark, NJ 07101-1709, USA.

Journal of the Neurological Sciences
|March 11, 2006
PubMed
Summary

This study reports the first cases of optic neuritis linked to adalimumab, a biologic drug targeting tumor necrosis factor-alpha. This finding is important for understanding potential side effects of anti-TNF therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

THRIVE: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Study of Veligrotug for Active Thyroid Eye Disease.

Ophthalmology·2026
Same author

Management of Binocular Diplopia With Prism Incorporated Ocular Impression-Based Scleral Lenses With and Without Wavefront-Guided Optics.

Eye & contact lens·2026
Same author

Should Patients With Ocular Myasthenia Gravis Be Started on Immunosuppression to Prevent Generalization?

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Between a Chiasm and a Hard Place.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Optic Atrophy in Wolfram Syndrome Type 1: A Retrospective Analysis of Visual Outcomes and Biomarker Correlates.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Reversible Cortical Visual Symptoms of Hyperosmolar Hyperglycemic State May Occur in Patients with Borderline Serum Osmolality.

Neuro-ophthalmology (Aeolus Press)·2026

Area of Science:

  • Ophthalmology
  • Neuroimmunology
  • Pharmacology

Background:

  • Adalimumab is a widely used anti-tumor necrosis factor-alpha (TNF-alpha) biologic medication.
  • TNF-alpha antagonists are known to have potential neurological side effects.
  • Optic neuritis is an inflammatory condition affecting the optic nerve.

Observation:

  • This paper details the first reported instances of optic neuritis occurring in patients treated with adalimumab.
  • The cases highlight a potential adverse event associated with this specific TNF-alpha antagonist.

Findings:

  • Adalimumab treatment was temporally associated with the onset of optic neuritis in the presented cases.
  • This suggests a possible causal link between adalimumab and optic neuritis.

Related Experiment Videos

Implications:

  • Clinicians should be aware of the potential risk of optic neuritis when prescribing adalimumab.
  • Further research is warranted to elucidate the mechanism and confirm the association between adalimumab and optic neuritis.
  • Monitoring for visual disturbances in patients receiving adalimumab may be beneficial.